Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic

被引:0
|
作者
Luca Roncati
Monica Roncati
机构
[1] University of Modena and Reggio Emilia,Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplantation, Oncology and Regenerative Medicine
[2] University of Modena and Reggio Emilia,Department of Biomedical, Metabolic and Neural Sciences
[3] Polyclinic Hospital,undefined
来源
Journal of Public Health Policy | 2021年 / 42卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:518 / 521
页数:3
相关论文
共 50 条
  • [21] Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
    Eastman, Richard T.
    Roth, Jacob S.
    Brimacombe, Kyle R.
    Simeonov, Anton
    Shen, Min
    Patnaik, Samarjit
    Hall, Matthew D.
    ACS CENTRAL SCIENCE, 2020, 6 (05) : 672 - 683
  • [22] The Precautionary Principle and Judicial Decision Making in the COVID-19 Pandemic
    Webber, Katie
    AUSTRALIAN JOURNAL OF ADMINISTRATIVE LAW, 2022, 29 (01): : 43 - 59
  • [23] An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19
    Singh, Awadhesh Kumar
    Singh, Akriti
    Singh, Ritu
    Misra, Anoop
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (02)
  • [24] Predictors of Willingness to Receive the COVID-19 Vaccine after Emergency Use Authorization: The Role of Coping Appraisal
    Xiao, Qianyi
    Liu, Xin
    Wang, Ruru
    Mao, Yimeng
    Chen, Hao
    Li, Xiaomei
    Liu, Xiaoxi
    Dai, Junming
    Gao, Junling
    Fu, Hua
    Zheng, Pinpin
    VACCINES, 2021, 9 (09)
  • [25] Evaluation of safety and effectiveness of remdesivir in treating COVID-19 patients after emergency use authorization study
    Burhan, Erlina
    Syahruddin, Elisna
    Isbaniah, Fathiyah
    Desianti, Ginanjar Arum
    Fachrucha, Fanny
    Sari, Cut Yulia Indah
    Ismail, Efriadi
    Astuti, Puji
    Maruli, Muhammad Farhan
    Mubarak, Farhan
    Rengganis, Anggit Tresna
    Bilqis, Hazia Hanifa
    Taslim, Imammurahman
    Sastria, Evan
    Wiyarta, Elvan
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [26] Rapid implementation of pharmacy infusion services for emergency use authorization COVID-19 treatments at a field hospital
    Rivera, Glorimar
    De Leon, Marisol
    Bernardelli, Beril
    Brannan, Barbara
    Dicubellis, Joseph
    Williams, Carla
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (22) : 2015 - 2019
  • [27] Emergency Use Authorization for Bamlanivimab in Mild to Moderate COVID-19 Implications for Clinical Nurse Specialist Practice
    O'Malley, Patricia Anne
    CLINICAL NURSE SPECIALIST, 2021, 35 (03) : 112 - 115
  • [28] FDA Emergency Use Authorization From 9/11 to COVID-19: Historical Lessons and Ethical Challenges
    Iwry, Jonathan L.
    FOOD AND DRUG LAW JOURNAL, 2021, 76 (02) : 337 - 380
  • [29] Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization
    Webb, Jamie
    Shah, Lesha D.
    Lynch, Holly Fernandez
    AMERICAN JOURNAL OF BIOETHICS, 2020, 20 (09): : 4 - 17
  • [30] Pharmacists' Perceptions and Drivers of Immunization Practices for COVID-19 Vaccines: Results of a Nationwide Survey Prior to COVID-19 Vaccine Emergency Use Authorization
    Jacob, Sonia Susan
    Bridgeman, Mary Barna
    Kim, Hyoeun
    Toscani, Michael
    Kohler, Racquel
    Shiau, Stephanie
    Jimenez, Humberto R.
    Barone, Joseph A.
    Narayanan, Navaneeth
    PHARMACY, 2021, 9 (03)